Señales en vivo de PRCT | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 jul 2024 @ 12:24):
Our systems believe the stock currently is undervalued by 0.17% compare to its pairs and should correct upwards.

Stats
Volumen de hoy	251 079
Volumen promedio	617 390
Capitalización de mercado	3.17B
EPS	$-0.510 ( Q1 \| 2024-05-02 )
Próxima fecha de ganancias	( $-0.520 ) 2024-07-25
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-29.12 (Sector) 42.63 (Industry) 0
ATR14	$0.136 (0.22%)

AEMD -5.55%

AFIB -13.04%

AHCO -3.25%

AHPI 0.00%

ALGN -0.35%

ANIK 2.18%

APEN 0.00%

APYX 2.24%

ARAY -2.47%

ATEC -4.74%

AXDX -4.27%

AXGN 4.70%

AXNX 0.07%

AZYO 2.05%

BBLG -1.15%

BIOL 5.00%

BJDX -0.57%

BMRA 4.55%

BRKR -2.46%

BSGM -2.88%

BWAY -2.63%

CERS -0.28%

CFMS 0.44%

CLPT 0.37%

CODX -1.62%

CSII 0.15%

CTKB 0.00%

CTSO 6.47%

CUTR 0.00%

CVRX -6.67%

DCTH -0.84%

DXCM -1.07%

DYNT -0.04%

EAR -4.10%

ECOR -2.33%

EDAP -2.96%

ESTA -4.94%

FONR 1.13%

HJLI -1.98%

HSDT 2.59%

HSKA 0.00%

HYPR 3.65%

IART -0.21%

ICAD -0.31%

ICCM -0.70%

IINN -11.59%

INGN -2.71%

INMD -0.77%

IRIX -0.36%

IRMD -1.64%

IRTC -0.59%

ISO 0.00%

ITMR 0.00%

KIDS -3.27%

LHDX 0.00%

LIVN 0.41%

LNSR -2.33%

LUCD -2.71%

LUNG -3.00%

MASS -5.92%

MDGS 10.28%

MOTS 16.31%

MOVE 5.13%

MSON 0.00%

NAOV 3.54%

NARI 2.60%

NMRD 33.33%

NNOX -2.83%

NPCE 0.53%

NTUS 0.00%

NURO 0.81%

NUVA -2.24%

NUWE -7.55%

NVCN 0.00%

NVNO -0.19%

OBLN -5.86%

OFIX -1.66%

OM -5.19%

PACB -6.67%

PAVM -1.96%

PETV -23.08%

PODD -1.17%

PRCT 1.05%

PROF 1.15%

QIPT -2.17%

QTRX -4.92%

RCEL -2.15%

RPID 2.80%

RSLS 0.78%

RWLK 6.07%

RXST -1.87%

SGHT -3.00%

SIBN -1.62%

SIEN -18.69%

SILK 0.00%

SINT -3.95%

SOLY 0.00%

SRDX -0.17%

SRGA 0.00%

SRTS -4.83%

SWAV 0.00%

TBIO 12.06%

TCMD -2.51%

TELA -1.91%

THMO 9.52%

TIVC 0.52%

TLIS -1.99%

TMCI -1.05%

TMDI 0.00%

TMDX 0.30%

TNDM -3.40%

TNON 17.79%

UFPT 5.70%

VERO -5.42%

VIVE 0.00%

VMD -2.29%

VRAY 0.00%

VREX -1.63%

VVOS 3.15%

XAIR 5.04%

XENT 0.00%

ZIMV 0.22%

Insider Trading

Date	Person	Action	Amount	type
2024-06-17	Nouri Alaleh	Sell	8 952	Common Stock
2024-06-17	Nouri Alaleh	Sell	1 048	Common Stock
2024-06-10	Shiblaq Hisham	Sell	26 046	Stock Option (Right to Buy)
2024-06-10	Shiblaq Hisham	Buy	26 046	Common Stock
2024-06-10	Shiblaq Hisham	Sell	26 046	Common Stock

INSIDER POWER
-80.03
Last 100 transactions
Buy: 767 556 \| Sell: 6 401 508

Correlación (AI algo v.1.1b): Undervalued: 0.17% $61.83 paired level. (El Algoritmo Rastrea Los Cambios De Las Acciones Más Correlacionadas En Tiempo Real Y Proporciona Una Actualización Instantánea)

Volumen Correlación

Largo: 0.03 (neutral)

Corto: 0.60 (weak)

Signal:(40.508) Neutral

PROCEPT BioRobotics Correlación

10 Correlaciones Más Positivas
LSAK	0.904
THCP	0.889
NTIC	0.882
CGEM	0.877
CHCI	0.874
SGMA	0.87
CADL	0.865
AGBA	0.86
AACI	0.86
IZEA	0.854

10 Correlaciones Más Negativas
CETX	-0.916
VAXX	-0.91
LINK	-0.892
INTC	-0.89
HOLI	-0.881
ARAY	-0.879
VRSN	-0.872
ICLK	-0.868
SECO	-0.867
HSDT	-0.86

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

PROCEPT BioRobotics Correlación - Moneda/Commodity

-0.21
( neutral )

0.02
( neutral )

0.00
( neutral )

-0.80
( moderate negative )

0.00
( neutral )

-0.49
( neutral )

PROCEPT BioRobotics Finanzas

Annual	2023
Ingresos:	$136.19M
Beneficio Bruto:	$71.05M (52.17 %)
EPS:	$-2.24

FY	2023
Ingresos:	$136.19M
Beneficio Bruto:	$71.05M (52.17 %)
EPS:	$-2.24

FY	2022
Ingresos:	$75.01M
Beneficio Bruto:	$37.09M (49.44 %)
EPS:	$-2.11

FY	2021
Ingresos:	$34.47M
Beneficio Bruto:	$15.87M (46.02 %)
EPS:	$-1.782

Financial Reports:

No articles found.

PROCEPT BioRobotics Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

PROCEPT BioRobotics

PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. As of December 31, 2021, it had an install base of 130 AquaBeam Robotic Systems worldwide comprising 78 in the United States. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in Redwood City, California.